Stock Analysts’ Updated EPS Estimates for February, 13th (AXON, BTU, BXG, CAPR, CRL, DEI, EMR, FRT, GBT, GHL)

Stock Analysts’ updated eps estimates for Tuesday, February 13th:

Axovant Sciences (NASDAQ:AXON) had its hold rating reiterated by analysts at Cowen Inc. The analysts wrote, “We maintain our BUY rating and $25 PT for SVRA shares.””

Peabody Energy (NYSE:BTU) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $43.00 price target on the stock. According to Zacks, “Peabody Energy Corporation is a coal company. It provides voice in advocating for sustainable mining, energy access and clean coal technologies. The company serves metallurgical and thermal coal customers primarily in Arizona, Colorado, New Mexico and Wyoming, Illinois, Indiana and Australia. Peabody Energy Corporation is based in St Louis, United States. “

Bluegreen Vacations (NYSE:BXG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $20.00 target price on the stock. According to Zacks, “Bluegreen Vacations Corporation provides vacation ownership company. It markets, sells and manages timeshare resorts, urban destinations, clubs and residential lands. Bluegreen Vacations Corporation is based in FL, United States. “

Capricor Therapeutics (NASDAQ:CAPR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.00 target price on the stock. According to Zacks, “Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. “

Charles River Laboratories Intl. (NYSE:CRL) had its buy rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $123.00 target price on the stock.

Douglas Emmett (NYSE:DEI) had its hold rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $39.00 price target on the stock.

Emerson Electric (NYSE:EMR) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating.

Federal Realty Investment Trust (NYSE:FRT) had its buy rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $142.00 price target on the stock.

Janney Montgomery Scott started coverage on shares of Global Blood Therapeutics (NASDAQ:GBT). Janney Montgomery Scott issued a buy rating on the stock.

Greenhill & Co., Inc. (NYSE:GHL) had its hold rating reissued by analysts at Sandler O’Neill. Sandler O’Neill currently has a $19.50 price target on the stock.

Himax Technologies (NASDAQ:HIMX) had its target price lowered by Roth Capital from $15.00 to $12.00. Roth Capital currently has a buy rating on the stock.

Instructure (NYSE:INST) had its price target increased by Oppenheimer Holdings Inc. from $41.00 to $43.00. They currently have an outperform rating on the stock.

Lions Gate Entertainment Co. Class A Voting Shares (NYSE:LGF.A) had its hold rating reaffirmed by analysts at Cowen Inc. They currently have a $26.00 target price on the stock.

Insperity (NYSE:NSP) had its price target raised by Roth Capital from $58.00 to $71.00. The firm currently has a buy rating on the stock.

Nova Measuring Instruments (NASDAQ:NVMI) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $34.00 target price on the stock.

Qualys (NASDAQ:QLYS) had its price target increased by Royal Bank of Canada to $65.00. The firm currently has a market perform rating on the stock.

RADCOM (NASDAQ:RDCM) had its buy rating reissued by analysts at William Blair.

UBS Group AG initiated coverage on shares of Recro Pharma (NASDAQ:REPH). The firm issued an outperform rating on the stock.

RingCentral (NYSE:RNG) had its price target boosted by Oppenheimer Holdings Inc. from $60.00 to $66.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.

RingCentral (NYSE:RNG) had its target price increased by Craig Hallum from $50.00 to $65.00. They currently have a buy rating on the stock.

RingCentral (NYSE:RNG) had its target price raised by SunTrust Banks, Inc. to $60.00. SunTrust Banks, Inc. currently has a buy rating on the stock.

RingCentral (NYSE:RNG) had its buy rating reissued by analysts at Stephens. They currently have a $60.00 target price on the stock.

Bancorp (NASDAQ:TBBK) had its hold rating reaffirmed by analysts at Piper Jaffray Companies.

Verona Pharma plc – American Depositary Share (NASDAQ:VRNA) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $33.00 price target on the stock.

Varonis Systems (NASDAQ:VRNS) had its buy rating reiterated by analysts at Stephens. The firm currently has a $60.00 price target on the stock.

Wix.Com (NASDAQ:WIX) had its buy rating reissued by analysts at SunTrust Banks, Inc.. They currently have a $71.00 price target on the stock. The analysts wrote, “We maintain our Buy rating and $71 PT on WIX. We expect WIX to report 4Q results in line with Street estimates when it reports on Wed. 2/14 (pre- open). As in recent quarters, we expect strong top-line growth, driven by robust user growth and higher ARPU. Management’s 2018 outlook along with its commentary on new product introductions/enhancements, and underlying business metrics (conversions, collections growth, marketing ROI, etc.) will be key to the stock post-print, in our view. We’ve lowered our 2018 EBITDA modestly to reflect costs for the Super Bowl ad.””

Receive News & Ratings for Axovant Sciences Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axovant Sciences Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply